
What we're about
Advancing prediction, prevention, and precision therapy for patients with rheumatic diseases
Who we are
Over 200 researchers spanning the basic, clinical, and analytical sciences
How we help
World-class core facilities and investigator support to drive groundbreaking research and launch distinctive careers
Why we care
Patients with rheumatic diseases need better tests and personalized treatments so they can live healthier, longer lives
Recent Publications
- Evaluating Anti-CCL25 as a Therapeutic Strategy to Disrupt Foci Formation in a Spontaneous Murine Model of Sjögren's Disease September 27, 2025
- Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland May 30, 2025
- Deep immunophenotyping reveals circulating activated lymphocytes in individuals at risk for rheumatoid arthritis March 17, 2025
- Disease diagnostics using machine learning of B cell and T cell receptor sequences February 20, 2025
- Association between antiphospholipid antibodies and diffuse alveolar haemorrhage risk in systemic lupus erythematosus: a systematic review and meta-analysis November 19, 2024
- Reply October 17, 2024
- Variants in the <em>DDX6-CXCR5</em> autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland July 29, 2024


